Corona Remedies Limited Share Price & Stock Analysis

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.

Key Metrics

Current Price	₹2,036.60
Market Cap	₹0 Cr
Sector	Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-Industry	Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products; Anti-infective Drugs; Gastrointestinal Drugs; Respiratory Drugs
P/E Ratio	67.3
52-Week Range	₹1,336.60 – ₹2,118.90
Dividend Yield	0.49%

Business Segments

1. Pharmaceuticals-100%

Frequently Asked Questions

What is the current share price of Corona Remedies Limited?

Corona Remedies Limited is trading at ₹2,036.60, with a market capitalisation of ₹0 Cr.

Which sector does Corona Remedies Limited belong to?

Corona Remedies Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products; Anti-infective Drugs; Gastrointestinal Drugs; Respiratory Drugs).

What are the key financial ratios of Corona Remedies Limited?

Corona Remedies Limited has a P/E of 67.3.